Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry
- PMID: 22622948
- DOI: 10.1007/s00406-012-0323-x
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry
Abstract
The current statement is a systematic review of the available data concerning the efficacy of medication treatment of bipolar disorder (BP). A systematic MEDLINE search was made concerning the treatment of BP (RCTs) with the names of treatment options as keywords. The search was updated on 10 March 2012. The literature suggests that lithium, first and second generation antipsychotics and valproate and carbamazepine are efficacious in the treatment of acute mania. Quetiapine and the olanzapine-fluoxetine combination are also efficacious for treating bipolar depression. Antidepressants should only be used in combination with an antimanic agent, because they can induce switching to mania/hypomania/mixed states/rapid cycling when utilized as monotherapy. Lithium, olanzapine, quetiapine and aripiprazole are efficacious during the maintenance phase. Lamotrigine is efficacious in the prevention of depression, and it remains to be clarified whether it is also efficacious for mania. There is some evidence on the efficacy of psychosocial interventions as an adjunctive treatment to medication. Electroconvulsive therapy is an option for refractory patients. In acute manic patients who are partial responders to lithium/valproate/carbamazepine, adding an antipsychotic is a reasonable choice. The combination with best data in acute bipolar depression is lithium plus lamotrigine. Patients stabilized on combination treatment might do worse if shifted to monotherapy during maintenance, and patients could benefit with add-on treatment with olanzapine, valproate, an antidepressant, or lamotrigine, depending on the index acute phase. A variety of treatment options for BP are available today, but still unmet needs are huge. Combination therapy may improve the treatment outcome but it also carries more side-effect burden. Further research is necessary as well as the development of better guidelines and algorithms for the step-by-step rational treatment.
Similar articles
-
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. doi: 10.3310/hta11390. Health Technol Assess. 2007. PMID: 17903393
-
Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.Int J Neuropsychopharmacol. 2008 Nov;11(7):999-1029. doi: 10.1017/S1461145708009231. Epub 2008 Aug 28. Int J Neuropsychopharmacol. 2008. PMID: 18752718
-
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. doi: 10.3310/hta8190. Health Technol Assess. 2004. PMID: 15147609
-
Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.CNS Neurosci Ther. 2011 Jun;17(3):167-77. doi: 10.1111/j.1755-5949.2009.00089.x. Epub 2009 Dec 15. CNS Neurosci Ther. 2011. PMID: 20015083 Free PMC article.
-
Haloperidol alone or in combination for acute mania.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004362. doi: 10.1002/14651858.CD004362.pub2. Cochrane Database Syst Rev. 2006. PMID: 16856043
Cited by
-
Development of an Emotion-Sensitive mHealth Approach for Mood-State Recognition in Bipolar Disorder.JMIR Ment Health. 2020 Jul 3;7(7):e14267. doi: 10.2196/14267. JMIR Ment Health. 2020. PMID: 32618577 Free PMC article.
-
Evaluation of left ventricular systolic and diastolic functions in bipolar patients during lithium therapy.Int J Clin Exp Med. 2015 Feb 15;8(2):2917-22. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25932255 Free PMC article.
-
The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.BMC Psychiatry. 2016 May 5;16:129. doi: 10.1186/s12888-016-0732-x. BMC Psychiatry. 2016. PMID: 27150464 Free PMC article. Clinical Trial.
-
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.Int J Neuropsychopharmacol. 2017 Feb 1;20(2):121-179. doi: 10.1093/ijnp/pyw100. Int J Neuropsychopharmacol. 2017. PMID: 27816941 Free PMC article. Review.
-
Effects of GADL1 overexpression on cell migration and the associated morphological changes.Sci Rep. 2019 Mar 28;9(1):5298. doi: 10.1038/s41598-019-41689-x. Sci Rep. 2019. PMID: 30923325 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical